ABSTRACT
Objective:
To describe the trend in incidence, mortality and Disability Adjusted Life Years of oral cancer in Latin America according to sex between 2000 and 2020.
Methods:
This ecological study extracted oral cancer information from 20 Latin American countries from the GBD-2020 database. Oral cancer burden was described by age-standardized rate (ASR) of incidence, mortality, and DALYs. The data was compared according to sex and countries. Trends (Average Annual Percentage Change-AAPC) were estimated for each indicator, sex, and country between 2000 and 2020 using Joint-point software.
Results:
Between 2000 and 2020, the highest incidence of oral cancer (ASR) occurred in Cuba (5.18), Brazil (4.38) and Uruguay (4.62). The countries with the highest mortality for both sexes were (ASR): Cuba (2.89), Brazil (2.71) and the Dominican Republic (2.58). The DALYs registered an average of 37.52 (Women: 22.39; Men: 52.62). The Dominican Republic reports increasing trends in incidence (AAPC: Men: 2.2; Women: 1.4), in mortality (AAPC: Men: 1.8; Women: 1.1), and in DALYs (AAPC: Men: 1.0; Women: 2.0). Costa Rica shows decreasing trends in men in incidence (AAPC: −1.3), mortality (AAPC: −1.6), and DALYs (AAPC: −1.8).
Conclusion:
Oral cancer shows increasing trends in: the incidence in both sexes in 10 countries, in mortality and DALYs in 6 countries, while the affectation between sexes does not show differences in trends.
Keywords:
Mouth neoplasms; Incidence; Mortality; Disability-adjusted life years; Latin America
RESUMEN
Objetivo:
Describir la tendencia de la incidencia, mortalidad y los Años de Vida Ajustados por Discapacidad del cáncer oral en América Latina según género entre los años 2000 y 2020.
Métodos:
Este estudio ecológico extrajo información del cáncer oral de 20 países de América Latina de la base de datos GBD-2020. La carga del cáncer oral se describió según tasa estandarizada por edad (ASR) de incidencia, mortalidad y AVAD. Se estimaron las tendencias (Promedio de cambio porcentual anual — AAPC) en cada indicador, género y país, entre el 2000 y el 2020 usando el software Joint-point.
Resultados:
Entre 2000 y 2020, la mayor incidencia de cáncer oral (ASR) se presentó en Cuba (5,18), Brasil (4,38) y Uruguay (4,62). Los países con mayor mortalidad para ambos géneros fueron: Cuba (2,89), Brasil (2,71) y República Dominicana (2,58). Los AVAD registraron un promedio de 37,52 (Mujeres: 22,39; Hombres: 52,62). República Dominicana reporta tendencias crecientes en la incidencia (AAPC: Hombres: 2,2; Mujeres: 1,4), en la mortalidad (AAPC: Hombres: 1,8; Mujeres: 1,1), y en los AVAD (AAPC: Hombres: 1,0; Mujeres: 2,0). Costa Rica muestra tendencias decrecientes en los hombres en incidencia (AAPC: −1,3), mortalidad (AAPC: −1,6) y AVAD (AAPC: −1,8).
Conclusiones:
El cáncer oral muestra tendencias al aumento en: la incidencia en ambos sexos en 10 países, en la mortalidad y los AVAD en 6 países, mientras la afectación entre sexos no muestra diferencias en las tendencias.
Palabras clave:
Cáncer oral; Incidencia; Mortalidad; Años de vida ajustados por discapacidad; América Latina
INTRODUCTION
Oral cancer is defined as any malignant neoplasm of the lip and oral cavity corresponding to the International Classification of Diseases [ICD-10] codes C00-C0811 World Health Organization. International Agency for Research on Cancer. Global Cancer Observatory. Home [Internet]. [cite don Apr. 21, 2022]. Available at: https://gco.iarc.fr/
https://gco.iarc.fr/...
. In 2018, the global estimate was 177,384 deaths and 354,864 new cases of cancerous lesions of the lips and oral cavity22 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424. https://doi.org/10.3322/caac.21492
https://doi.org/10.3322/caac.21492...
. Oral cancer is the fourth most common cancer and the sixth leading cause of cancer death in low- and middle-income people33 Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144(8): 1941-53. https://doi.org/10.1002/IJC.31937
https://doi.org/10.1002/IJC.31937...
. This cancer also shares risk factors with other chronic noncommunicable diseases, has high mortality, and is unevenly distributed around the world (>50% in low-income countries).
Worldwide, the age-standardized rate (ASR) for oral cancer is 6.0 for men and 2.3 for women per 100,000 population. The highest burden of oral cancer is recorded in South America, Southeast Asia (India, Sri Lanka, Pakistan, Bangladesh, and Taiwan) and the Pacific regions (Papua New Guinea and Melanesia)55 Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol 2015; 8(9): 11884-94. PMID: 26617944. By 2040, an incidence of around 553,000 cases and 263,000 deaths from oral cancer is expected worldwide, with an increase of almost 34% and 48% in mortality compared to 202066 World Health Organization. International Agency for Research on Cancer. Global Cancer Observatory. Cancer tomorrow. Estimated number of new cases from 2020 to 2040, both sexes, age [0-85+] [Internet] 2020. [cited on Feb. 2, 2022]. Available at: https://gco.iarc.fr/tomorrow/en/dataviz/bars?mode=population&cancers=1&bar_mode=stacked
https://gco.iarc.fr/tomorrow/en/dataviz/...
. In Latin America, the data is similar to the world average, presenting an adjusted rate of 3.58 for men and 2.42 for women77 Herrera-Serna BYH, Lara-Carrillo E, Toral-Rizo VH, Amaral RC. Comparación entre incidencia y factores de riesgo de cáncer oral en diferentes países de América Latina. Rev Salud Pública 2020; 24(2): 49-63. https://doi.org/10.31052/1853.1180.v24.n2.24336
https://doi.org/10.31052/1853.1180.v24.n...
.
Herrera-Serna et al.77 Herrera-Serna BYH, Lara-Carrillo E, Toral-Rizo VH, Amaral RC. Comparación entre incidencia y factores de riesgo de cáncer oral en diferentes países de América Latina. Rev Salud Pública 2020; 24(2): 49-63. https://doi.org/10.31052/1853.1180.v24.n2.24336
https://doi.org/10.31052/1853.1180.v24.n...
report that the incidence between 2000 and 2017 shows a growth trend in Latin America. These trends have shown a relationship with an unequal distribution in the region of the main risk factors associated with oral cancer. There is a positive relationship between the incidence of oral cancer and smoking (r: 0.37; p<0.01), and with alcohol consumption (r: 0.60; p<0.01) in men. Bray et al.22 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424. https://doi.org/10.3322/caac.21492
https://doi.org/10.3322/caac.21492...
state that by 2030 the burden of oral cancer in Central and South America will increase by approximately 7% (72,985 new cases and 37,909 deaths).
Geographic location seems to be one of the key variables for oral cancer88 Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin 2017; 67(1): 51-64. https://doi.org/10.3322/CAAC.21384
https://doi.org/10.3322/CAAC.21384...
. This is because the population belonging to a certain area is exposed to different sociocultural and economic risks99 Du M, Nair R, Jamieson L, Liu Z, Bi P. Incidence trends of lip, oral cavity, and pharyngeal cancers: global burden of disease 1990-2017. J Dent Res 2020; 99(2): 143-51. https://doi.org/10.1177/0022034519894963
https://doi.org/10.1177/0022034519894963...
, so information on incidence and mortality by country is important for formulating policies, monitoring trends in incidence and mortality, and planning prevention based on solid scientific evidence.
In addition to these two parameters, it is important to determine the burden of oral cancer to provide a clearer idea of the psychosocial, physical, emotional, and financial impact that the population suffers from this disease, specifically identifying the indicator “disability-adjusted life years” (DALY) that consolidates mortality, the time lived with disability and the severity of the pathology1010 Gold MR, Stevenson D, Fryback DG. HALYS and QALYS and DALYS, oh my: similarities and differences in summary measures of population health. Annu Rev Public Health 2002; 23: 115-34. https://doi.org/10.1146/annurev.publhealth.23.100901.140513
https://doi.org/10.1146/annurev.publheal...
,1111 Harris JA, Ritchie CA, Hanna GJ, McCain JP, Ji YD. The inequitable global burden of lip and oral cancers: widening disparities across countries. J Oral Maxillofac Surg 2021; 79(6): 1364-72. https://doi.org/10.1016/j.joms.2020.12.035
https://doi.org/10.1016/j.joms.2020.12.0...
.
The Global Burden of Disease (GBD) study provides a unique data set for 359 diseases (including lip and oral cavity cancer) in 195 countries and territories around the world. GBD 2020 includes mortality from 282 specific causes of death in 195 regions and countries around the world between 1990 and 2020, as well as health losses from 359 diseases and injuries associated with DALYs. The present study aimed to describe the trend of incidence, mortality, and disability-adjusted life years of oral cancer in Latin America using data from GBD 2020.
METHODS
This ecological study extracted data on the incidence, mortality, and DALYs of oral cancer in 20 countries in Latin America and the Caribbean (LAC), from the GBD 2020 database.
The etiological code used in GBD 2020 was based on the ICD formulated by the World Health Organization (WHO), which is the current standard in the world and the most exhaustive list of causes. The definition of oral cancer in GBD 2020 consisted of codes C00-C08 (cancer of the lip and oral cavity) in ICD10
Details on the modeling strategy for oral cancer data are available in Kassebaum et al.1212 Kassebaum NJ, Smith AGC, Bernabé E, Fleming TD, Reynolds AE, Vos T, et al. Global, regional, and national prevalence, incidence, and disability-adjusted life years for oral conditions for 195 countries, 1990-2015: a systematic analysis for the global burden of diseases, injuries, and risk factors. J Dent Res 2017; 96(4): 380-7. https://doi.org/10.1177/0022034517693566
https://doi.org/10.1177/0022034517693566...
. ASR data per 100,000 population were retrieved for oral cancer incidence, mortality, and DALYs by gender and for each of the 20 LAC countries. The strategy for data extraction from the GBD outcomes tool included: incidence, deaths, and DALYs; years 2000 to 2020; neoplasm of the oral cavity and lips; the 20 LAC countries; men and women; and age-standardized rates. All data and results can be obtained from the global health database (Global Health Exchange — GHDx) on the GBD1313 Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392(10159): 1859-922. https://doi.org/10.1016/S0140-6736(18)32335-3
https://doi.org/10.1016/S0140-6736(18)32...
website. The GHDx source tools provided a complete list of basic data (http://ghdx.healthdata.org/data-type/disease-registry).
This research followed the principles of the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER)1414 Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. PLoS Med 2016; 13(6): e1002056. https://doi.org/10.1371/journal.pmed.1002056
https://doi.org/10.1371/journal.pmed.100...
and was endorsed by the Research Ethics Committee of a university.
To define trends in oral cancer incidence, mortality, and DALYs, a joint-point regression analysis was performed to calculate the average annual percent change (AAPC) and the uncertainty interval (UI). It was performed using the Jointpoint regression analysis program, version 4.7.0.0, provided by the US National Cancer Institute. The Jointpoint regression analysis was based on the search method of a minimum number of 2 observations from a Jointpoint to select the best fit piecewise continuous logarithmic linear model. The period in years was the independent variable, while incidence, mortality, and DALYs were the dependent ones, assuming homoscedasticity over the years. Regression models were adjusted for gender and country. The uncertainty intervals for the annual percentage change (APC) in each segment, when more than one was identified, and for the AAPC in all cases, were determined using the parametric method and the permutation test method for model selection with an overall significance level of 0.051515 Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joint-point regression with applications to cancer rates. Stat Med 2000; 19(3): 335-51. https://doi.org/10.1002/(SICI)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z
https://doi.org/10.1002/(SICI)1097-0258(...
. For better interpretation, it was estimated that the trend was increasing when its sign was positive and its interval did not include zero, stable when the interval included zero, and decreasing when its sign was negative and did not include zero1616 Perea LME, Peres MA, Boing AF, Antunes JLF. Trend of oral and pharyngeal cancer mortality in Brazil in the period of 2002 to 2013. Rev Saude Publica 2018; 52: 10. https://doi.org/10.11606/S1518-8787.2018052000251
https://doi.org/10.11606/S1518-8787.2018...
. All plots of the Jointpoint regression analyses are provided in the supplementary material.
RESULTS
The highest incidence between 2000 and 2020 in men occurred in Uruguay (ASR 2000: 7.49; 2020: 6.98), Brazil (ASR 2000: 71.18; 2020: 6034), and Cuba (ASR 2000: 6.87; 2020: 8.78) and the lowest in Ecuador (ASR 2000: 1.35; 2020: 1.68). Among women, the highest incidence was observed in Cuba (ASR 2000: 2.53; 2020: 2.55) and in the Dominican Republic (ASR 2000: 2.18; 2020: 2.85); and the lowest in Nicaragua (ASR 2000: 0.88; 2020: 1.11) and in Chile (ASR 2000: 0.92; 2020: 1.06). Mortality rates are higher for men in Brazil (ASR 2000: 4.46, 2020: 3.75), Cuba (ASR 2000: 3.99, 2020: 4.77), and Uruguay (ASR 2000: 3.61, 2020: 3.98); and the lowest in Ecuador (ASR 2000: 0.92; 2020: 1.11) and Peru (ASR 2000: 1.00; 2020: 0.86). Women from the Dominican Republic had the highest mortality (ASR 2000: 1.87; 2020: 1.48), and women from Chile the lowest (ASR 2000: 0.58; 2020: 0.58). Again, men from Brazil (ASR 2000: 124.84; 2020: 101.08), Cuba (ASR 2000: 119.04; 2020: 98.87), and Uruguay (ASR 2000: 95.71; 2020: 108.74) the most affected according to DALYs (Supplemental Material, Table 1, Figures 1–6).
Average annual percent change of oral cancer incidence by gender and country between 2000 and 2020 in Latin America and the Caribbean.
Trend analysis
Jointpoint analysis yielded graphics and estimates for incidence, mortality, and DALYs by gender and country. When there was a change in trend, the software estimated each section as a joint-point and determined the APC, with its uncertainty interval and p-value for each period, according to the best fit to the line. All graphics are attached in the supplementary material. For the full time period (2000–2020), the AAPC was estimated with its uncertainty interval and statistical significance (Tables 1–3). The final model that yields the estimates for the entire period is the one that achieves the best fit after 5,000 estimates. For both genders, the Dominican Republic reports increasing trends in incidence (AAPC: Men: 2.2; Women: 1.4), in mortality (AAPC: Men: 1.8; Women: 1.1), and in DALYs (AAPC: Men: 1.0; Women: 2.0). Costa Rica shows decreasing trends in men in incidence (AAPC: −1.3), mortality (AAPC: −1.6), and DALYs (AAPC: −1.8).
Average Annual Percentage Change in oral cancer mortality by gender and country between 2000 and 2020 in Latin America and the Caribbean.
Average Annual Percent Change in disability-adjusted life years due to oral cancer by gender and country between 2000 and 2020 in Latin America and the Caribbean.
In the supplementary material, it can be seen that the Central American countries presented the greatest variations for the three indicators and both genders, among which El Salvador and Panama stand out with the identification of up to 4 different segments during the period. While the least variable behavior, with 1 jointpoint, was seen in the increased incidence in women from Argentina and men in Cuba; increased mortality of men in Cuba; and increased DALYs for women in the Dominican Republic and for men in Cuba. It is not possible to identify a specific year or period in which the greatest variations have occurred.
DISCUSSION
Cancer is a noncommunicable disease with one of the highest mortality rates worldwide, its great multifactoriality makes it a major public health problem for nations1717 Bittar TO, Paranhos LR, Fornazari DH, Pereira AC. Epidemiologia do câncer bucal: um problema mundial de saúde pública. RFO 2010; 15(1): 87-93. https://doi.org/10.5335/rfo.v15i1.1023
https://doi.org/10.5335/rfo.v15i1.1023...
. In the present study, the average mortality from oral cancer for both genders in Latin America was 1.56; being higher in Cuba, Brazil, and Uruguay.
Incidence and mortality could be related, like other similar pathologies, to the problem of access to health services. According to the study published by Houghton et al.1818 Houghton N, Bascolo E, Del Riego A. Monitoring access barriers to health services in the Americas: a mapping of household surveys. Rev Panam Salud Publica 2020; 44: e96. https://doi.org/10.26633/RPSP.2020.96
https://doi.org/10.26633/RPSP.2020.96...
, multiple barriers to health services can be identified, including people forgoing care because they cannot afford it, or insufficient availability of resources for the provision of health care or failures in the organization and provision of health care, due to the location of one's home or the facility.
In the present study, the age-standardized rates of incidence, mortality, and DALYs showed important differences between countries. Various social behaviors and customs can contribute to the incidence of oral cancer, and even these differences have been observed to occur in countries that are geographically close to each other1919 Rahman QB, Iocca O, Kufta K, Shanti RM. Global burden of head and neck cancer. Oral Maxillofac Surg Clin North Am 2020; 32(3): 367-75. https://doi.org/10.1016/J.COMS.2020.04.002
https://doi.org/10.1016/J.COMS.2020.04.0...
. It is also possible that these differences are explained by the existence of underreporting. In low- and middle-income countries, where health care facilities are limited or few, cancer registry data may be of poor quality or may be less than occurred. For example, cancer registration in Asia, Africa, and Latin America is generally restricted to urban populations. The vast majority of rural populations are not covered2020 Jedy-Agba EE, Oga EA, Odutola M, Abdullahi YM, Popoola A, Achara P, et al. Developing national cancer registration in developing countries – case study of the Nigerian National System of Cancer Registries. Front Public Health 2015; 3: 186. https://doi.org/10.3389/FPUBH.2015.00186
https://doi.org/10.3389/FPUBH.2015.00186...
. Good epidemiological information is essential so that cancer control programs can be planned efficiently, not only to implement standards of care but also to define prevention strategies2121 Valsecchi MG, Steliarova-Foucher E. Cancer registration in developing countries: luxury or necessity? Lancet Oncol 2008; 9(2): 159-67. https://doi.org/10.1016/S1470-2045(08)70028-7
https://doi.org/10.1016/S1470-2045(08)70...
.
DALYs for oral cancer registered an average for Latin America of 37.52 for both genders. In this regard, Harris et al.1111 Harris JA, Ritchie CA, Hanna GJ, McCain JP, Ji YD. The inequitable global burden of lip and oral cancers: widening disparities across countries. J Oral Maxillofac Surg 2021; 79(6): 1364-72. https://doi.org/10.1016/j.joms.2020.12.035
https://doi.org/10.1016/j.joms.2020.12.0...
indicated a 14.8% increase in the global burden in that period from 1990 to 2017, with a higher burden in the more developed countries, but an unequal distribution within the less developed countries. In this study, indeed, the region is below the world average (51.1)1111 Harris JA, Ritchie CA, Hanna GJ, McCain JP, Ji YD. The inequitable global burden of lip and oral cancers: widening disparities across countries. J Oral Maxillofac Surg 2021; 79(6): 1364-72. https://doi.org/10.1016/j.joms.2020.12.035
https://doi.org/10.1016/j.joms.2020.12.0...
, but some countries, such as Brazil and Cuba, show higher values in men.
The GBD 2019 study found that, globally, the majority of cancer-related DALYs (96.9%; 95%UI 96.0–97.7) in 2019 came from years of life lost (YLL), which suggests that total loss of health from cancer was primarily associated with premature death. This finding is a valuable reminder of the importance of working to improve overall survival results, which is also related to the stage at which it is diagnosed and treatment is started2222 Mateo-Sidrón Antón MC, Somacarrera Pérez ML. Cáncer oral: genética, prevención, diagnóstico y tratamiento. Revisión de la literatura. Av Odontoestomatol 2015; 31(4): 247-59. https://doi.org/10.4321/S0213-12852015000400002
https://doi.org/10.4321/S0213-1285201500...
–2424 Schoonbeek RC, Zwertbroek J, Plaat BEC, Takes RP, Ridge JA, Strojan P, et al. Determinants of delay and association with outcome in head and neck cancer: a systematic review. Eur J Surg Oncol 2021; 47(8): 1816-27. https://doi.org/10.1016/j.ejso.2021.02.029
https://doi.org/10.1016/j.ejso.2021.02.0...
, age (9% higher in those under 40 years)2525 Oliver JR, Wu SP, Chang CM, Roden DF, Wang B, Hu KS, et al. Survival of oral tongue squamous cell carcinoma in young adults. Head Neck 2019; 41(9): 2960-8. https://doi.org/10.1002/hed.25772
https://doi.org/10.1002/hed.25772...
, gender (higher in women)2626 Li H, Park HS, Osborn HA, Judson BL. Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas. Cancers Head Neck 2018; 3: 4. https://doi.org/10.1186/s41199-018-0031-y
https://doi.org/10.1186/s41199-018-0031-...
, and ethnicity (less in blacks)2727 Shin JY, Yoon JK, Shin AK, Diaz AZ. The influence of insurance status on treatment and outcomes in oral cavity cancer: an analysis on 46,373 patients. Int J Oral Maxillofac Surg 2018; 47(10): 1250-7. https://doi.org/10.1016/j.ijom.2018.03.022
https://doi.org/10.1016/j.ijom.2018.03.0...
,2828 Lewis CM, Ajmani GS, Kyrillos A, Chamberlain P, Wang CH, Nocon CC, et al. Racial disparities in the choice of definitive treatment for squamous cell carcinoma of the oral cavity. Head Neck 2018; 40(11): 2372-82. https://doi.org/10.1002/hed.25341
https://doi.org/10.1002/hed.25341...
, factors that have been shown to influence a better prognosis. The present study confirms that the most affected populations in terms of DALYs were those with the highest mortality (men from Cuba and Uruguay in 2020).
The increase in average DALYs in Latin American countries (except Panama in both genders) could be explained by the epidemiological transition theory, according to which communicable diseases gradually give way to noncommunicable diseases as a society progressively matures through different stages of socioeconomic development. This is how the average mortality and burden of oral cancer can be determined by the change in risk factors for cancer, such as diets with low intakes of fruits and vegetables and social habits such as tobacco and alcohol consumption3030 Shrestha AD, Vedsted P, Kallestrup P, Neupane D. Prevalence and incidence of oral cancer in low- and middle-income countries: a scoping review. Eur J Cancer Care (Engl) 2020; 29(2): e13207. https://doi.org/10.1111/ecc.13207
https://doi.org/10.1111/ecc.13207...
. Cuba has had less progress in the implementation of tobacco and alcohol control policies, which is consistent with its higher prevalence of tobacco consumption (average of 55% between 2005 and 2015) and alcohol consumption (average of 9.37 liters per capita between 2010 and 2016)3131 Herrera-Serna BY, Lara-Carrillo E, Toral-Rizo VH, Amaral RC. Efecto de las políticas de control de factores de riesgo sobre la mortalidad por cáncer oral en América Latina. Rev Esp Salud Publica 2019; 93: e201907050..
Societies that have gone through the early stages of socioeconomic development, like most Latin American countries, are already experiencing a consistently high burden of noncommunicable diseases due to long-standing inappropriate lifestyle habits, social behaviors of more developed economies, and longer life expectancy3232 Harris JA, Ritchie CA, Hanna GJ, McCain JP, Ji YD. The inequitable global burden of lip and oral cancers: widening disparities across countries. J Oral Maxillofac Surg 2021; 79(6): 1364-72. https://doi.org/10.1016/j.joms.2020.12.035
https://doi.org/10.1016/j.joms.2020.12.0...
.
The AAPC trend in mortality and the trend in DALYs from oral cancer by gender and country between 2000 and 2020 in Latin America and the Caribbean is stable or increasing in 11 of the 20 countries. The results described in this research indicate that an increase in the incidence of oral cancer and related mortality can be anticipated in Latin America. Based on global figures, it appears that low- to middle-income countries are likely to have the greatest impact in the future with the increased burden of oral cancer3333 Patterson RH, Fischman VG, Wasserman I, Siu J, Shrime MG, Fagan JJ, et al. Global burden of head and neck cancer: economic consequences, health, and the role of surgery. Otolaryngol Head Neck Surg 2020; 162(3): 296-303. https://doi.org/10.1177/0194599819897265
https://doi.org/10.1177/0194599819897265...
. Given that there is an intrinsic link between health and economic growth, the data provided by this work can support interventions that foster a bidirectional impact on both health and the economy, which is essential in Latin American countries that are, most of them, developing. These figures also suggest the need for increased cancer prevention and control efforts to reduce the current burden3434 Franceschi S, Wild CP. Meeting the global demands of epidemiologic transition – the indispensable role of cancer prevention. Mol Oncol 2013; 7(1): 1-13. https://doi.org/10.1016/j.molonc.2012.10.010
https://doi.org/10.1016/j.molonc.2012.10...
as well as the need to accelerate progress in locations with lower Human Development Indexes to reduce the effect of the increasing burden3535 Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 2018; 392(10159): 2052-90. https://doi.org/10.1016/S0140-6736(18)31694-5
https://doi.org/10.1016/S0140-6736(18)31...
,3636 Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012; 13(8): 790-801. https://doi.org/10.1016/S1470-2045(12)70211-5
https://doi.org/10.1016/S1470-2045(12)70...
. Although most countries have implemented changes in health insurance systems, there are still limitations to achieving an ideal both in terms of resources invested per person and in the homogenization of the set of services covered3737 Báscolo E, Houghton N, Del Riego A. Lógicas de transformación de los sistemas de salud en América Latina y resultados en acceso y cobertura de salud. Rev Panam Salud Publica 2018; 42: e126. https://doi.org/10.26633/RPSP.2018.126
https://doi.org/10.26633/RPSP.2018.126...
.
No specific period or year was identified in which changes in trend directions occurred. This can be related to sustained, albeit uneven, changes in the health care systems of the countries of the region, as well as the implementation of different policies both in the health sector, which seek to improve access, and in other related sectors such as employment, the fundamental basis of social security in the region. International evidence on the effect of policies that seek to avoid financial barriers to access to health is extensive and diverse3838 O'Connell TS, Bedford KJA, Thiede M, McIntyre D. Synthesizing qualitative and quantitative evidence on non-financial access barriers: implications for assessment at the district level. Int J Equity Health 2015; 14: 54. https://doi.org/10.1186/s12939-015-0181-z
https://doi.org/10.1186/s12939-015-0181-...
,3939 Nandi S, Schneider H. Using an equity-based framework for evaluating publicly funded health insurance programmes as an instrument of UHC in Chhattisgarh State, India. Health Res Policy Syst 2020; 18(1): 50. https://doi.org/10.1186/s12961-020-00555-3
https://doi.org/10.1186/s12961-020-00555...
, but agrees that despite the expansion of health programs that have managed to increase coverage and use of services4040 Erlangga D, Suhrcke M, Ali S, Bloor K. The impact of public health insurance on health care utilisation, financial protection and health status in low- and middle-income countries: a systematic review. PLoS One 2019; 14(8): e0219731. https://doi.org/10.1371/journal.pone.0219731
https://doi.org/10.1371/journal.pone.021...
, other barriers can affect the effectiveness and diffusion of these policies4141 Allen EM, Call KT, Beebe TJ, McAlpine DD, Johnson PJ. Barriers to care and health care utilization among the publicly insured. Med Care 2017; 55(3): 207-14. https://doi.org/10.1097/MLR.0000000000000644
https://doi.org/10.1097/MLR.000000000000...
.
The main limitations of the present study include reliance on secondary data, which in turn is affected by measurement precision, changes in case definition, and heterogeneity in study designs. However, as GBD evolves and matures, its estimation techniques have become more accurate and reliable. Those statistical estimates provide a completer and more continuous picture of the epidemiology of the disease than relying on raw data from isolated studies. Ultimately, the goal is to guide decision-making in clinical care and public health policy.
This systematic analysis of the GBD 2020 study provides comprehensive and comparable estimates of the burden of oral cancer in Latin America and the Caribbean. Such estimates are vital to improving equity in Latin American oral cancer outcomes and achieving key targets of the Sustainable Development Goals (SDGs) to reduce the burden of cancer and other noncommunicable diseases. This is relevant given that the trends show increases and greater impact in countries with less sociodemographic development.
Therefore, oral cancer shows increasing trends in incidence in both genders in 10 countries, while mortality and DALYs show increases in 6 countries. This suggests that, in some contexts, the pathology may be being controlled, although the affectation between genders does not show differences in trends. These estimates are vital to improving equity in Latin American oral cancer outcomes and achieving key SDG targets to reduce the burden of cancer and other noncommunicable diseases.
-
ETHICS COMMITTEE: Number of approval of the Research Ethics Committee: This study is part of a project entitled: Carga de enfermedades orales en América Latina, and is under the corresponding approval of Universidad Autónoma de Manizales, according to minutes 707-109.
-
FUNDING: none.
ACKNOWLEDGMENTS:
We thank Universidad Autónoma de Manizales for supporting research training spaces for students and teachers.
REFERENCES
-
1World Health Organization. International Agency for Research on Cancer. Global Cancer Observatory. Home [Internet]. [cite don Apr. 21, 2022]. Available at: https://gco.iarc.fr/
» https://gco.iarc.fr/ -
2Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424. https://doi.org/10.3322/caac.21492
» https://doi.org/10.3322/caac.21492 -
3Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144(8): 1941-53. https://doi.org/10.1002/IJC.31937
» https://doi.org/10.1002/IJC.31937 -
4World Health Organization. International Agency for Research on Cancer. Global Cancer Observatory. Cancer today. Estimated number of new cases in 2020, worldwide, both sexes, all ages [Internet] 2020. [cite don Feb. 2, 2022]. Available at: https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=1&include_nmsc_other=1
» https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=1&include_nmsc_other=1 -
5Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol 2015; 8(9): 11884-94. PMID: 26617944
-
6World Health Organization. International Agency for Research on Cancer. Global Cancer Observatory. Cancer tomorrow. Estimated number of new cases from 2020 to 2040, both sexes, age [0-85+] [Internet] 2020. [cited on Feb. 2, 2022]. Available at: https://gco.iarc.fr/tomorrow/en/dataviz/bars?mode=population&cancers=1&bar_mode=stacked
» https://gco.iarc.fr/tomorrow/en/dataviz/bars?mode=population&cancers=1&bar_mode=stacked -
7Herrera-Serna BYH, Lara-Carrillo E, Toral-Rizo VH, Amaral RC. Comparación entre incidencia y factores de riesgo de cáncer oral en diferentes países de América Latina. Rev Salud Pública 2020; 24(2): 49-63. https://doi.org/10.31052/1853.1180.v24.n2.24336
» https://doi.org/10.31052/1853.1180.v24.n2.24336 -
8Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin 2017; 67(1): 51-64. https://doi.org/10.3322/CAAC.21384
» https://doi.org/10.3322/CAAC.21384 -
9Du M, Nair R, Jamieson L, Liu Z, Bi P. Incidence trends of lip, oral cavity, and pharyngeal cancers: global burden of disease 1990-2017. J Dent Res 2020; 99(2): 143-51. https://doi.org/10.1177/0022034519894963
» https://doi.org/10.1177/0022034519894963 -
10Gold MR, Stevenson D, Fryback DG. HALYS and QALYS and DALYS, oh my: similarities and differences in summary measures of population health. Annu Rev Public Health 2002; 23: 115-34. https://doi.org/10.1146/annurev.publhealth.23.100901.140513
» https://doi.org/10.1146/annurev.publhealth.23.100901.140513 -
11Harris JA, Ritchie CA, Hanna GJ, McCain JP, Ji YD. The inequitable global burden of lip and oral cancers: widening disparities across countries. J Oral Maxillofac Surg 2021; 79(6): 1364-72. https://doi.org/10.1016/j.joms.2020.12.035
» https://doi.org/10.1016/j.joms.2020.12.035 -
12Kassebaum NJ, Smith AGC, Bernabé E, Fleming TD, Reynolds AE, Vos T, et al. Global, regional, and national prevalence, incidence, and disability-adjusted life years for oral conditions for 195 countries, 1990-2015: a systematic analysis for the global burden of diseases, injuries, and risk factors. J Dent Res 2017; 96(4): 380-7. https://doi.org/10.1177/0022034517693566
» https://doi.org/10.1177/0022034517693566 -
13Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392(10159): 1859-922. https://doi.org/10.1016/S0140-6736(18)32335-3
» https://doi.org/10.1016/S0140-6736(18)32335-3 -
14Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. PLoS Med 2016; 13(6): e1002056. https://doi.org/10.1371/journal.pmed.1002056
» https://doi.org/10.1371/journal.pmed.1002056 -
15Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joint-point regression with applications to cancer rates. Stat Med 2000; 19(3): 335-51. https://doi.org/10.1002/(SICI)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z
» https://doi.org/10.1002/(SICI)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z -
16Perea LME, Peres MA, Boing AF, Antunes JLF. Trend of oral and pharyngeal cancer mortality in Brazil in the period of 2002 to 2013. Rev Saude Publica 2018; 52: 10. https://doi.org/10.11606/S1518-8787.2018052000251
» https://doi.org/10.11606/S1518-8787.2018052000251 -
17Bittar TO, Paranhos LR, Fornazari DH, Pereira AC. Epidemiologia do câncer bucal: um problema mundial de saúde pública. RFO 2010; 15(1): 87-93. https://doi.org/10.5335/rfo.v15i1.1023
» https://doi.org/10.5335/rfo.v15i1.1023 -
18Houghton N, Bascolo E, Del Riego A. Monitoring access barriers to health services in the Americas: a mapping of household surveys. Rev Panam Salud Publica 2020; 44: e96. https://doi.org/10.26633/RPSP.2020.96
» https://doi.org/10.26633/RPSP.2020.96 -
19Rahman QB, Iocca O, Kufta K, Shanti RM. Global burden of head and neck cancer. Oral Maxillofac Surg Clin North Am 2020; 32(3): 367-75. https://doi.org/10.1016/J.COMS.2020.04.002
» https://doi.org/10.1016/J.COMS.2020.04.002 -
20Jedy-Agba EE, Oga EA, Odutola M, Abdullahi YM, Popoola A, Achara P, et al. Developing national cancer registration in developing countries – case study of the Nigerian National System of Cancer Registries. Front Public Health 2015; 3: 186. https://doi.org/10.3389/FPUBH.2015.00186
» https://doi.org/10.3389/FPUBH.2015.00186 -
21Valsecchi MG, Steliarova-Foucher E. Cancer registration in developing countries: luxury or necessity? Lancet Oncol 2008; 9(2): 159-67. https://doi.org/10.1016/S1470-2045(08)70028-7
» https://doi.org/10.1016/S1470-2045(08)70028-7 -
22Mateo-Sidrón Antón MC, Somacarrera Pérez ML. Cáncer oral: genética, prevención, diagnóstico y tratamiento. Revisión de la literatura. Av Odontoestomatol 2015; 31(4): 247-59. https://doi.org/10.4321/S0213-12852015000400002
» https://doi.org/10.4321/S0213-12852015000400002 -
23Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45(4-5): 309-16. https://doi.org/10.1016/j.oraloncology.2008.06.002
» https://doi.org/10.1016/j.oraloncology.2008.06.002 -
24Schoonbeek RC, Zwertbroek J, Plaat BEC, Takes RP, Ridge JA, Strojan P, et al. Determinants of delay and association with outcome in head and neck cancer: a systematic review. Eur J Surg Oncol 2021; 47(8): 1816-27. https://doi.org/10.1016/j.ejso.2021.02.029
» https://doi.org/10.1016/j.ejso.2021.02.029 -
25Oliver JR, Wu SP, Chang CM, Roden DF, Wang B, Hu KS, et al. Survival of oral tongue squamous cell carcinoma in young adults. Head Neck 2019; 41(9): 2960-8. https://doi.org/10.1002/hed.25772
» https://doi.org/10.1002/hed.25772 -
26Li H, Park HS, Osborn HA, Judson BL. Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas. Cancers Head Neck 2018; 3: 4. https://doi.org/10.1186/s41199-018-0031-y
» https://doi.org/10.1186/s41199-018-0031-y -
27Shin JY, Yoon JK, Shin AK, Diaz AZ. The influence of insurance status on treatment and outcomes in oral cavity cancer: an analysis on 46,373 patients. Int J Oral Maxillofac Surg 2018; 47(10): 1250-7. https://doi.org/10.1016/j.ijom.2018.03.022
» https://doi.org/10.1016/j.ijom.2018.03.022 -
28Lewis CM, Ajmani GS, Kyrillos A, Chamberlain P, Wang CH, Nocon CC, et al. Racial disparities in the choice of definitive treatment for squamous cell carcinoma of the oral cavity. Head Neck 2018; 40(11): 2372-82. https://doi.org/10.1002/hed.25341
» https://doi.org/10.1002/hed.25341 -
29Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q 2005; 83(4): 731-57. https://doi.org/10.1111/j.1468-0009.2005.00398.x
» https://doi.org/10.1111/j.1468-0009.2005.00398.x -
30Shrestha AD, Vedsted P, Kallestrup P, Neupane D. Prevalence and incidence of oral cancer in low- and middle-income countries: a scoping review. Eur J Cancer Care (Engl) 2020; 29(2): e13207. https://doi.org/10.1111/ecc.13207
» https://doi.org/10.1111/ecc.13207 -
31Herrera-Serna BY, Lara-Carrillo E, Toral-Rizo VH, Amaral RC. Efecto de las políticas de control de factores de riesgo sobre la mortalidad por cáncer oral en América Latina. Rev Esp Salud Publica 2019; 93: e201907050.
-
32Harris JA, Ritchie CA, Hanna GJ, McCain JP, Ji YD. The inequitable global burden of lip and oral cancers: widening disparities across countries. J Oral Maxillofac Surg 2021; 79(6): 1364-72. https://doi.org/10.1016/j.joms.2020.12.035
» https://doi.org/10.1016/j.joms.2020.12.035 -
33Patterson RH, Fischman VG, Wasserman I, Siu J, Shrime MG, Fagan JJ, et al. Global burden of head and neck cancer: economic consequences, health, and the role of surgery. Otolaryngol Head Neck Surg 2020; 162(3): 296-303. https://doi.org/10.1177/0194599819897265
» https://doi.org/10.1177/0194599819897265 -
34Franceschi S, Wild CP. Meeting the global demands of epidemiologic transition – the indispensable role of cancer prevention. Mol Oncol 2013; 7(1): 1-13. https://doi.org/10.1016/j.molonc.2012.10.010
» https://doi.org/10.1016/j.molonc.2012.10.010 -
35Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 2018; 392(10159): 2052-90. https://doi.org/10.1016/S0140-6736(18)31694-5
» https://doi.org/10.1016/S0140-6736(18)31694-5 -
36Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012; 13(8): 790-801. https://doi.org/10.1016/S1470-2045(12)70211-5
» https://doi.org/10.1016/S1470-2045(12)70211-5 -
37Báscolo E, Houghton N, Del Riego A. Lógicas de transformación de los sistemas de salud en América Latina y resultados en acceso y cobertura de salud. Rev Panam Salud Publica 2018; 42: e126. https://doi.org/10.26633/RPSP.2018.126
» https://doi.org/10.26633/RPSP.2018.126 -
38O'Connell TS, Bedford KJA, Thiede M, McIntyre D. Synthesizing qualitative and quantitative evidence on non-financial access barriers: implications for assessment at the district level. Int J Equity Health 2015; 14: 54. https://doi.org/10.1186/s12939-015-0181-z
» https://doi.org/10.1186/s12939-015-0181-z -
39Nandi S, Schneider H. Using an equity-based framework for evaluating publicly funded health insurance programmes as an instrument of UHC in Chhattisgarh State, India. Health Res Policy Syst 2020; 18(1): 50. https://doi.org/10.1186/s12961-020-00555-3
» https://doi.org/10.1186/s12961-020-00555-3 -
40Erlangga D, Suhrcke M, Ali S, Bloor K. The impact of public health insurance on health care utilisation, financial protection and health status in low- and middle-income countries: a systematic review. PLoS One 2019; 14(8): e0219731. https://doi.org/10.1371/journal.pone.0219731
» https://doi.org/10.1371/journal.pone.0219731 -
41Allen EM, Call KT, Beebe TJ, McAlpine DD, Johnson PJ. Barriers to care and health care utilization among the publicly insured. Med Care 2017; 55(3): 207-14. https://doi.org/10.1097/MLR.0000000000000644
» https://doi.org/10.1097/MLR.0000000000000644
Publication Dates
-
Publication in this collection
14 Nov 2022 -
Date of issue
2022
History
-
Received
02 June 2022 -
Reviewed
13 Sept 2022 -
Accepted
20 Sept 2022